Economic Outcomes of Maintenance Gefitinib for Locally Advanced/Metastatic Non-Small-Cell Lung Cancer with Unknown EGFR Mutations: A Semi-Markov Model Analysis

BACKGROUND: Maintenance gefitinib significantly prolonged progression-free survival (PFS) compared with placebo in patients from eastern Asian with locally advanced/metastatic non-small-cell lung cancer (NSCLC) after four chemotherapeutic cycles (21 days per cycle) of first-line platinum-based combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xiaohui, Li, Jianhe, Peng, Liubao, Wang, Yunhua, Tan, Chongqing, Chen, Gannong, Wan, Xiaomin, Lu, Qiong, Yi, Lidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930593/
https://www.ncbi.nlm.nih.gov/pubmed/24586426
http://dx.doi.org/10.1371/journal.pone.0088881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930593/
https://www.ncbi.nlm.nih.gov/pubmed/24586426
http://dx.doi.org/10.1371/journal.pone.0088881

Ejemplares similares